| Target Price | $255.00 |
| Price | $175.02 |
| Potential | 45.70% |
| Number of Estimates | 61 |
| 61 Analysts have issued a price target NVIDIA 2026 . The average NVIDIA target price is $255.00. This is 45.70% higher than the current stock price. The highest price target is $454.42 159.64% , the lowest is $139.38 20.36% . | |
| A rating was issued by 72 analysts: 64 Analysts recommend NVIDIA to buy, 7 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the NVIDIA stock has an average upside potential 2026 of 45.70% . Most analysts recommend the NVIDIA stock at Purchase. |
68 Analysts have issued a sales forecast NVIDIA 2026 . The average NVIDIA sales estimate is $217b . This is 15.97% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $227b 21.18% , the lowest is $200b 6.72% .
This results in the following potential growth metrics:
| 2025 | $130b | 114.20% |
|---|---|---|
| 2026 | $217b | 66.32% |
| 2027 | $331b | 52.46% |
| 2028 | $418b | 26.24% |
| 2029 | $414b | 0.94% |
| 2030 | $490b | 18.53% |
| 2031 | $567b | 15.52% |
| 2032 | $635b | 12.01% |
| 2033 | $710b | 11.90% |
31 Analysts have issued an NVIDIA EBITDA forecast 2026. The average NVIDIA EBITDA estimate is $134b . This is 18.58% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $143b 26.53% , the lowest is $125b 10.28% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2025 | $83.9b | 139.07% |
|---|---|---|
| 2026 | $134b | 59.96% |
| 2027 | $192b | 42.67% |
| 2028 | $260b | 35.68% |
| 2029 | $274b | 5.63% |
| 2030 | $305b | 10.97% |
| 2031 | $358b | 17.40% |
| 2032 | $359b | 0.46% |
| 2033 | $399b | 11.03% |
| 2025 | 64.31% | 11.61% |
|---|---|---|
| 2026 | 61.85% | 3.82% |
| 2027 | 57.88% | 6.42% |
| 2028 | 62.21% | 7.48% |
| 2029 | 66.33% | 6.62% |
| 2030 | 62.10% | 6.38% |
68 NVIDIA Analysts have issued a net profit forecast 2026. The average NVIDIA net profit estimate is $116b . This is 16.85% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $126b 27.35% , the lowest is $108b 8.77% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | $72.9b | 144.89% |
|---|---|---|
| 2026 | $116b | 59.05% |
| 2027 | $189b | 62.80% |
| 2028 | $238b | 25.86% |
| 2029 | $262b | 10.40% |
| 2030 | $303b | 15.40% |
| 2031 | $321b | 6.10% |
| 2032 | $365b | 13.75% |
| 2033 | $413b | 13.10% |
| 2025 | 55.85% | 14.33% |
|---|---|---|
| 2026 | 53.41% | 4.37% |
| 2027 | 57.03% | 6.78% |
| 2028 | 56.86% | 0.30% |
| 2029 | 63.37% | 11.45% |
| 2030 | 61.69% | 2.65% |
| 2031 | 56.66% | 8.15% |
| 2032 | 57.54% | 1.55% |
| 2033 | 58.15% | 1.06% |
68 Analysts have issued a NVIDIA forecast for earnings per share. The average NVIDIA EPS is $4.77 . This is 17.78% higher than earnings per share in the financial year 2025. The highest EPS forecast is $5.20 28.40% , the lowest is $4.44 9.63% .
This results in the following potential growth metrics and future valuations:
| 2025 | $2.94 | 147.06% |
|---|---|---|
| 2026 | $4.77 | 62.24% |
| 2027 | $7.76 | 62.68% |
| 2028 | $9.77 | 25.90% |
| 2029 | $10.79 | 10.44% |
| 2030 | $12.45 | 15.38% |
| 2031 | $13.21 | 6.10% |
| 2032 | $15.02 | 13.70% |
| 2033 | $16.99 | 13.12% |
| Current | 43.21 | 22.94% |
|---|---|---|
| 2026 | 36.70 | 15.08% |
| 2027 | 22.54 | 38.58% |
| 2028 | 17.91 | 20.54% |
| 2029 | 16.22 | 9.44% |
| 2030 | 14.06 | 13.32% |
| 2031 | 13.25 | 5.76% |
| 2032 | 11.65 | 12.08% |
| 2033 | 10.30 | 11.59% |
Based on analysts' sales estimates for 2026, the NVIDIA stock is valued at an EV/Sales of 19.36 and an P/S ratio of 19.60 .
This results in the following potential growth metrics and future valuations:
| Current | 22.45 | 26.47% |
|---|---|---|
| 2026 | 19.36 | 13.78% |
| 2027 | 12.70 | 34.41% |
| 2028 | 10.06 | 20.78% |
| 2029 | 10.15 | 0.95% |
| 2030 | 8.56 | 15.64% |
| 2031 | 7.41 | 13.44% |
| 2032 | 6.62 | 10.73% |
| 2033 | 5.91 | 10.64% |
| Current | 22.73 | 26.21% |
|---|---|---|
| 2026 | 19.60 | 13.77% |
| 2027 | 12.85 | 34.41% |
| 2028 | 10.18 | 20.78% |
| 2029 | 10.28 | 0.94% |
| 2030 | 8.67 | 15.64% |
| 2031 | 7.51 | 13.44% |
| 2032 | 6.70 | 10.73% |
| 2033 | 5.99 | 10.64% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Dec 01 2025 |
| Argus Research |
Buy
➜
Buy
|
Unchanged | Nov 20 2025 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Nov 20 2025 |
| Bernstein |
Outperform
➜
Outperform
|
Unchanged | Nov 20 2025 |
| Benchmark |
Buy
➜
Buy
|
Unchanged | Nov 20 2025 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Nov 20 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Nov 20 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Dec 01 2025 |
|
Unchanged
Argus Research:
Buy
➜
Buy
|
Nov 20 2025 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Nov 20 2025 |
|
Unchanged
Bernstein:
Outperform
➜
Outperform
|
Nov 20 2025 |
|
Unchanged
Benchmark:
Buy
➜
Buy
|
Nov 20 2025 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Nov 20 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Nov 20 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


